Lee Silsby Compounding Pharmacy (Gipsco Investment Corp.), Cleveland Heights, OH

Is Lee Silsby Compounding Pharmacy (Gipsco Investment Corp.) registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Lee Silsby Compounding Pharmacy (Gipsco Investment Corp.) hold a Ohio pharmacy license?

State board of pharmacy records for Ohio are not checked: the board’s website rejected automated requests and the state’s eLicense lookup answers them with a script check, and this index does not work around blocks.

Has Lee Silsby Compounding Pharmacy (Gipsco Investment Corp.) had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter close-out (Jan 5, 2023), 1 state handoff letter (Jan 5, 2023) and 1 FMD-145 letter (Jan 5, 2023) for Lee Silsby Compounding Pharmacy (Gipsco Investment Corp.). State board of pharmacy records for Ohio are not checked: the board’s website rejected automated requests and the state’s eLicense lookup answers them with a script check, and this index does not work around blocks. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Gipsco Investment Corp.; Lee Silsby Compounding Pharmacy
Location
Cleveland Heights, OH
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
0
Warning letters on FDA’s actions page
0
Latest action on that page
Jan 5, 2023
FDA Data Dashboard inspections
No matching site found
State board records
Not checked

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Gipsco Investment Corp. (dba Lee Silsby Compounding Pharmacy), a 503A facility, with 3 dated actions.

Document
Jan 5, 2023State handoff letterState Handoff Letter Issued 01/05/2023Not linked by FDA
Jan 5, 2023FMD-145 letterFMD-145 Issued 01/05/2023Not linked by FDA
Jan 5, 2023Warning letter close-outWarning Letter Close Out Issued 01/05/2023Not linked by FDA

An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.

The dashboard does list Gipsco Investment Corp, Beachwood, OH (FEI 3005457901): same name and state, different city, so not treated as this site.

State board of pharmacy records

State board of pharmacy records for Ohio are not checked: the board’s website rejected automated requests and the state’s eLicense lookup answers them with a script check, and this index does not work around blocks.

This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.